Vera-Peralta Heidy, Ruffié Claude, Najburg Valérie, Brione Matthias, Combredet Chantal, Frantz Phanramphoei, Tournier Jean-Nicolas, Tangy Frédéric, Mura Marie
Institut Pasteur-Oncovita Joint Laboratory, Université Paris Cité, Institut Pasteur, Paris, France.
Interactions hôte-pathogène, Institut de Recherche Biomédicale des Armées, Brétigny-sur-Orge, France.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2436241. doi: 10.1080/21645515.2024.2436241. Epub 2024 Dec 18.
Measles live attenuated vaccine (MV) induces strong humoral and cellular systemic memory responses allowing the successful control of measles since decades. MV has also been adapted into a promising vaccine platform with several vaccine candidates in clinical development. To understand and document the tissue-scaled memory response induced by MV, we explored the specific induction and persistence of resident memory T cells (Trm) in the lungs and the liver, two critical targeted tissues for vaccine development against several diseases. Trm are a subset of non-circulating highly specialized T cells. They are found at multiple barrier and mucosal sites, conveniently positioned to rapidly react against pathogens. The induction of Trm in different tissues is therefore critical for vaccine development. We demonstrated in mice the rapid generation of MV-specific and vectorized antigen-specific Trm in the liver and the lungs after a single dose, whatever the route of immunization. The intranasal route induced more Trm in the lungs than other routes, confirming the potential of intranasal vaccine administration of replicative viral vectors to generate a strong pulmonary immune response. MV-specific Trm cells were functionally active, with CD8 Trm secreting granzyme B upon in vitro restimulation and CD4 Trm cells secreting IFN-γ and TNF-α. We confirmed in human lymphocytes this tissue tropism by showing an overexpression of homing receptors directing them to epithelial and inflamed tissues. Vaccination strategies able to induce Trm cells at key sites represent a promising field to improve current vaccines, prioritize vaccine platforms and design future vaccines with enhanced protective efficacy.
麻疹减毒活疫苗(MV)诱导产生强大的体液和细胞全身性记忆反应,数十年来一直能成功控制麻疹。MV还已被改造成一个有前景的疫苗平台,有几种候选疫苗正在临床开发中。为了了解和记录MV诱导的组织尺度记忆反应,我们探索了驻留记忆T细胞(Trm)在肺和肝中的特异性诱导和持久性,肺和肝是针对多种疾病的疫苗开发的两个关键靶组织。Trm是一类非循环的高度特化T细胞亚群。它们存在于多个屏障和黏膜部位,便于快速对病原体作出反应。因此,在不同组织中诱导Trm对于疫苗开发至关重要。我们在小鼠中证明,无论免疫途径如何,单剂量接种后,肝和肺中能快速产生MV特异性和载体化抗原特异性Trm。鼻内途径在肺中诱导产生的Trm比其他途径更多,这证实了鼻内接种复制性病毒载体疫苗产生强大肺部免疫反应的潜力。MV特异性Trm细胞具有功能活性,CD8 Trm在体外再次刺激时分泌颗粒酶B,CD4 Trm细胞分泌干扰素-γ和肿瘤坏死因子-α。我们通过显示归巢受体在人淋巴细胞中的过表达,证实了这种组织嗜性,这些归巢受体可将它们导向上皮组织和炎症组织。能够在关键部位诱导Trm细胞的疫苗接种策略是一个有前景的领域,可用于改进现有疫苗、确定疫苗平台的优先级以及设计具有增强保护效力的未来疫苗。